September 12, 2014
Symetis Receives CE Mark Approval for Transfemoral Transcatheter Aortic Heart Valve System ACURATE neo™, and Launches Product With First Commercial Implantations

September 8, 2014
Endeavour Medtech Growth Fund surpasses target with a successful first close at EUR 80m (USD 105m)

September 8, 2014
Western Digital Capital Makes Strategic Investment in Amplidata

September 2, 2014
Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing

July 8, 2014
Sophia Genetics raises Series B round led by Invoke Capital

© Endeavour Vision SA 2006-2014 Terms & Conditions